Compare STRO & AFCG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | STRO | AFCG |
|---|---|---|
| Founded | 2003 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 85.0M | 68.5M |
| IPO Year | 2018 | 2021 |
| Metric | STRO | AFCG |
|---|---|---|
| Price | $11.82 | $2.73 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 8 | 4 |
| Target Price | ★ $18.29 | $5.75 |
| AVG Volume (30 Days) | 101.4K | ★ 303.4K |
| Earning Date | 11-06-2025 | 11-12-2025 |
| Dividend Yield | N/A | ★ 20.48% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $105,646,000.00 | N/A |
| Revenue This Year | $63.08 | N/A |
| Revenue Next Year | N/A | $2.19 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.23 | $2.52 |
| 52 Week High | $21.50 | $8.88 |
| Indicator | STRO | AFCG |
|---|---|---|
| Relative Strength Index (RSI) | 75.24 | 42.32 |
| Support Level | $10.15 | $2.77 |
| Resistance Level | $12.18 | $3.04 |
| Average True Range (ATR) | 0.93 | 0.20 |
| MACD | -0.19 | -0.01 |
| Stochastic Oscillator | 85.66 | 4.17 |
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.
Advanced Flower Capital Inc is a commercial mortgage REIT that provides institutional loans to cannabis operators in the U.S. Through the management team's deep network and related credit and cannabis expertise. The company originates, structures, and underwrites loans secured by quality real estate assets, license value, and cash flows.